Precision genomics,
one secure cloud.
Serapis unifies sample intake, bioinformatics, variant interpretation and clinical reporting in a single audited cloud environment.
RESEARCHER PORTAL
Sign in to continue
For clinical geneticists, laboratory staff and bioinformaticians
Trusted with genomic data by leading institutions
A complete operating system for genomics
Every step of the molecular workflow — sequenced, annotated, interpreted and reported — inside one governed environment.
Variant annotation
Automated cross-check against ClinVar, OMIM, gnomAD, dbSNP and your internal knowledge base.
Cloud-native storage
Versioned storage for FASTQ, BAM, CRAM and VCF with per-cohort access policies.
Analytics & QC
Dashboards for sample flow, coverage, contamination, turnaround time and reporting KPIs.
Clinical reporting
Sign-out templates with HL7 FHIR export, audit trail and electronic signature.
Interoperability
HL7 FHIR, REST, webhooks and pre-built connectors for LIS, EMR and hospital MIS.
Team collaboration
Case conferences, inline variant comments, review queues and role-based approvals.
Security by default
Encryption at rest and in transit, scoped tokens, MFA and immutable audit logs.
Reproducible pipelines
Version-pinned Nextflow pipelines with container digests and full provenance.
Global compliance
ISO 27001, ISO 13485 aligned, GDPR, HIPAA-ready with regional data residency.
From tube to report in five governed stages
Accessioning
Barcoded sample intake with full chain of custody.
Sequencing
Instrument-agnostic run tracking and real-time QC.
Bioinformatics
Pinned Nextflow pipelines for alignment, calling and annotation.
Interpretation
ACMG/AMP-guided review with structured evidence.
Reporting
Signed clinical report delivered as PDF and FHIR.
Live laboratory throughput
Real-time visibility into sample intake, pipeline runs and signed reports across every connected lab.
- Per-instrument run monitoring and QC trending
- Coverage, contamination and duplicate-rate alerts
- Turnaround-time KPIs and cohort tracking
Where Serapis is used
From hereditary cancer to population-scale screening.
Hereditary cancer syndromes
BRCA1/2, Lynch, TP53 and multigene panels with cascade testing support.
Learn moreUndiagnosed rare disease
WES and WGS for pediatric and adult rare disease diagnostics.
Learn morePersonalized prescribing
CYP450 and DPYD guided dosing with CDS-ready outputs.
Learn morePortfolio by research area
Across the Serapis network, oncology programs remain the largest share of clinical volume, followed by rare-disease diagnostics and pharmacogenomics.
- Oncogenetics · 38% of volume
- Rare disease · 27% of volume
- Pharmacogenomics · 19% of volume
Trusted by clinical and research leaders
Recent publications
Rapid WGS in critically ill neonates: a multi-site implementation study
Learn moreMachine-assisted ACMG classification reduces curator variance
Learn moreBring your lab onto Serapis
We will map your pipeline, integrate with your LIS and train your team — usually in under a month.